世界のミトコンドリアミオパチー市場規模・現状・予測2021-2027

【英語タイトル】Global Mitochondrial Myopathies Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR3823)・商品コード:QY21APR3823
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:92
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、ミトコンドリアミオパチーの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(筋生検、血液酵素検査、遺伝子検査)、用途別市場規模(病院、クリニック、疾病研究開発機関)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・ミトコンドリアミオパチーの市場動向
・企業の競争状況、市場シェア
・ミトコンドリアミオパチーの種類別市場規模(筋生検、血液酵素検査、遺伝子検査)
・ミトコンドリアミオパチーの用途別市場規模(病院、クリニック、疾病研究開発機関)
・ミトコンドリアミオパチーの北米市場規模2016-2027(アメリカ、カナダ)
・ミトコンドリアミオパチーの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・ミトコンドリアミオパチーのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・ミトコンドリアミオパチーの中南米市場規模2016-2027(メキシコ、ブラジル)
・ミトコンドリアミオパチーの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Reata Pharmaceuticals、Stealth Biotherapeutics、Raptor Pharmaceutical、Raym Genedx、Neurovive Pharmaceutical)
・結論
【レポートの概要】

Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate “ragged red” muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an increased reactivity for succinate dehydrogenase and a decreased reactivity for cytochrome c oxidase.
The identification of patients with possible MM depends upon the investigation of multiple organ dysfunction in the clinical history, examination, and clinical tests. Although there is no disease-modifying therapy for MM, there are numerous points of clinical relevance that can reduce morbidity and improve quality of life for patients with these disorders.

Market Analysis and Insights: Global Mitochondrial Myopathies Market
The global Mitochondrial Myopathies market size is projected to reach US$ 42 million by 2026, from US$ 25 million in 2019, at a CAGR of 7.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mitochondrial Myopathies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mitochondrial Myopathies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mitochondrial Myopathies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mitochondrial Myopathies market.

Global Mitochondrial Myopathies Scope and Market Size
Mitochondrial Myopathies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mitochondrial Myopathies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Muscle Biopsy
Blood Enzyme Test
Genetic Test

Segment by Application
Hospitals
Clinics
Disease Research and Development Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Reata Pharmaceuticals
Stealth Biotherapeutics
Raptor Pharmaceutical
Raym Genedx
Neurovive Pharmaceutical

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mitochondrial Myopathies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Muscle Biopsy
1.2.3 Blood Enzyme Test
1.2.4 Genetic Test
1.3 Market by Application
1.3.1 Global Mitochondrial Myopathies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Disease Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Mitochondrial Myopathies Market Perspective (2016-2027)
2.2 Mitochondrial Myopathies Growth Trends by Regions
2.2.1 Mitochondrial Myopathies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mitochondrial Myopathies Historic Market Share by Regions (2016-2021)
2.2.3 Mitochondrial Myopathies Forecasted Market Size by Regions (2022-2027)
2.3 Mitochondrial Myopathies Industry Dynamic
2.3.1 Mitochondrial Myopathies Market Trends
2.3.2 Mitochondrial Myopathies Market Drivers
2.3.3 Mitochondrial Myopathies Market Challenges
2.3.4 Mitochondrial Myopathies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Mitochondrial Myopathies Players by Revenue
3.1.1 Global Top Mitochondrial Myopathies Players by Revenue (2016-2021)
3.1.2 Global Mitochondrial Myopathies Revenue Market Share by Players (2016-2021)
3.2 Global Mitochondrial Myopathies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mitochondrial Myopathies Revenue
3.4 Global Mitochondrial Myopathies Market Concentration Ratio
3.4.1 Global Mitochondrial Myopathies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mitochondrial Myopathies Revenue in 2020
3.5 Mitochondrial Myopathies Key Players Head office and Area Served
3.6 Key Players Mitochondrial Myopathies Product Solution and Service
3.7 Date of Enter into Mitochondrial Myopathies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Mitochondrial Myopathies Breakdown Data by Type
4.1 Global Mitochondrial Myopathies Historic Market Size by Type (2016-2021)
4.2 Global Mitochondrial Myopathies Forecasted Market Size by Type (2022-2027)

5 Mitochondrial Myopathies Breakdown Data by Application
5.1 Global Mitochondrial Myopathies Historic Market Size by Application (2016-2021)
5.2 Global Mitochondrial Myopathies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Mitochondrial Myopathies Market Size (2016-2027)
6.2 North America Mitochondrial Myopathies Market Size by Type
6.2.1 North America Mitochondrial Myopathies Market Size by Type (2016-2021)
6.2.2 North America Mitochondrial Myopathies Market Size by Type (2022-2027)
6.2.3 North America Mitochondrial Myopathies Market Size by Type (2016-2027)
6.3 North America Mitochondrial Myopathies Market Size by Application
6.3.1 North America Mitochondrial Myopathies Market Size by Application (2016-2021)
6.3.2 North America Mitochondrial Myopathies Market Size by Application (2022-2027)
6.3.3 North America Mitochondrial Myopathies Market Size by Application (2016-2027)
6.4 North America Mitochondrial Myopathies Market Size by Country
6.4.1 North America Mitochondrial Myopathies Market Size by Country (2016-2021)
6.4.2 North America Mitochondrial Myopathies Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Mitochondrial Myopathies Market Size (2016-2027)
7.2 Europe Mitochondrial Myopathies Market Size by Type
7.2.1 Europe Mitochondrial Myopathies Market Size by Type (2016-2021)
7.2.2 Europe Mitochondrial Myopathies Market Size by Type (2022-2027)
7.2.3 Europe Mitochondrial Myopathies Market Size by Type (2016-2027)
7.3 Europe Mitochondrial Myopathies Market Size by Application
7.3.1 Europe Mitochondrial Myopathies Market Size by Application (2016-2021)
7.3.2 Europe Mitochondrial Myopathies Market Size by Application (2022-2027)
7.3.3 Europe Mitochondrial Myopathies Market Size by Application (2016-2027)
7.4 Europe Mitochondrial Myopathies Market Size by Country
7.4.1 Europe Mitochondrial Myopathies Market Size by Country (2016-2021)
7.4.2 Europe Mitochondrial Myopathies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Mitochondrial Myopathies Market Size (2016-2027)
8.2 Asia-Pacific Mitochondrial Myopathies Market Size by Type
8.2.1 Asia-Pacific Mitochondrial Myopathies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mitochondrial Myopathies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mitochondrial Myopathies Market Size by Type (2016-2027)
8.3 Asia-Pacific Mitochondrial Myopathies Market Size by Application
8.3.1 Asia-Pacific Mitochondrial Myopathies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mitochondrial Myopathies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mitochondrial Myopathies Market Size by Application (2016-2027)
8.4 Asia-Pacific Mitochondrial Myopathies Market Size by Region
8.4.1 Asia-Pacific Mitochondrial Myopathies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mitochondrial Myopathies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Mitochondrial Myopathies Market Size (2016-2027)
9.2 Latin America Mitochondrial Myopathies Market Size by Type
9.2.1 Latin America Mitochondrial Myopathies Market Size by Type (2016-2021)
9.2.2 Latin America Mitochondrial Myopathies Market Size by Type (2022-2027)
9.2.3 Latin America Mitochondrial Myopathies Market Size by Type (2016-2027)
9.3 Latin America Mitochondrial Myopathies Market Size by Application
9.3.1 Latin America Mitochondrial Myopathies Market Size by Application (2016-2021)
9.3.2 Latin America Mitochondrial Myopathies Market Size by Application (2022-2027)
9.3.3 Latin America Mitochondrial Myopathies Market Size by Application (2016-2027)
9.4 Latin America Mitochondrial Myopathies Market Size by Country
9.4.1 Latin America Mitochondrial Myopathies Market Size by Country (2016-2021)
9.4.2 Latin America Mitochondrial Myopathies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Mitochondrial Myopathies Market Size (2016-2027)
10.2 Middle East & Africa Mitochondrial Myopathies Market Size by Type
10.2.1 Middle East & Africa Mitochondrial Myopathies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mitochondrial Myopathies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mitochondrial Myopathies Market Size by Type (2016-2027)
10.3 Middle East & Africa Mitochondrial Myopathies Market Size by Application
10.3.1 Middle East & Africa Mitochondrial Myopathies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mitochondrial Myopathies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mitochondrial Myopathies Market Size by Application (2016-2027)
10.4 Middle East & Africa Mitochondrial Myopathies Market Size by Country
10.4.1 Middle East & Africa Mitochondrial Myopathies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mitochondrial Myopathies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Reata Pharmaceuticals
11.1.1 Reata Pharmaceuticals Company Details
11.1.2 Reata Pharmaceuticals Business Overview
11.1.3 Reata Pharmaceuticals Mitochondrial Myopathies Introduction
11.1.4 Reata Pharmaceuticals Revenue in Mitochondrial Myopathies Business (2016-2021)
11.1.5 Reata Pharmaceuticals Recent Development
11.2 Stealth Biotherapeutics
11.2.1 Stealth Biotherapeutics Company Details
11.2.2 Stealth Biotherapeutics Business Overview
11.2.3 Stealth Biotherapeutics Mitochondrial Myopathies Introduction
11.2.4 Stealth Biotherapeutics Revenue in Mitochondrial Myopathies Business (2016-2021)
11.2.5 Stealth Biotherapeutics Recent Development
11.3 Raptor Pharmaceutical
11.3.1 Raptor Pharmaceutical Company Details
11.3.2 Raptor Pharmaceutical Business Overview
11.3.3 Raptor Pharmaceutical Mitochondrial Myopathies Introduction
11.3.4 Raptor Pharmaceutical Revenue in Mitochondrial Myopathies Business (2016-2021)
11.3.5 Raptor Pharmaceutical Recent Development
11.4 Raym Genedx
11.4.1 Raym Genedx Company Details
11.4.2 Raym Genedx Business Overview
11.4.3 Raym Genedx Mitochondrial Myopathies Introduction
11.4.4 Raym Genedx Revenue in Mitochondrial Myopathies Business (2016-2021)
11.4.5 Raym Genedx Recent Development
11.5 Neurovive Pharmaceutical
11.5.1 Neurovive Pharmaceutical Company Details
11.5.2 Neurovive Pharmaceutical Business Overview
11.5.3 Neurovive Pharmaceutical Mitochondrial Myopathies Introduction
11.5.4 Neurovive Pharmaceutical Revenue in Mitochondrial Myopathies Business (2016-2021)
11.5.5 Neurovive Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Mitochondrial Myopathies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Muscle Biopsy
Table 3. Key Players of Blood Enzyme Test
Table 4. Key Players of Genetic Test
Table 5. Global Mitochondrial Myopathies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Mitochondrial Myopathies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Mitochondrial Myopathies Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Mitochondrial Myopathies Market Share by Regions (2016-2021)
Table 9. Global Mitochondrial Myopathies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Mitochondrial Myopathies Market Share by Regions (2022-2027)
Table 11. Mitochondrial Myopathies Market Trends
Table 12. Mitochondrial Myopathies Market Drivers
Table 13. Mitochondrial Myopathies Market Challenges
Table 14. Mitochondrial Myopathies Market Restraints
Table 15. Global Mitochondrial Myopathies Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Mitochondrial Myopathies Market Share by Players (2016-2021)
Table 17. Global Top Mitochondrial Myopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitochondrial Myopathies as of 2020)
Table 18. Ranking of Global Top Mitochondrial Myopathies Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Mitochondrial Myopathies Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Mitochondrial Myopathies Product Solution and Service
Table 22. Date of Enter into Mitochondrial Myopathies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Mitochondrial Myopathies Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Mitochondrial Myopathies Revenue Market Share by Type (2016-2021)
Table 26. Global Mitochondrial Myopathies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Mitochondrial Myopathies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Mitochondrial Myopathies Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Mitochondrial Myopathies Revenue Market Share by Application (2016-2021)
Table 30. Global Mitochondrial Myopathies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Mitochondrial Myopathies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Mitochondrial Myopathies Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Mitochondrial Myopathies Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Mitochondrial Myopathies Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Mitochondrial Myopathies Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Mitochondrial Myopathies Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Mitochondrial Myopathies Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Mitochondrial Myopathies Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Mitochondrial Myopathies Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Mitochondrial Myopathies Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Mitochondrial Myopathies Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Mitochondrial Myopathies Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Mitochondrial Myopathies Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Mitochondrial Myopathies Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Mitochondrial Myopathies Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Mitochondrial Myopathies Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Mitochondrial Myopathies Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Mitochondrial Myopathies Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Mitochondrial Myopathies Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Mitochondrial Myopathies Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Mitochondrial Myopathies Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Mitochondrial Myopathies Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Mitochondrial Myopathies Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Mitochondrial Myopathies Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Mitochondrial Myopathies Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Mitochondrial Myopathies Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Mitochondrial Myopathies Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Mitochondrial Myopathies Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Mitochondrial Myopathies Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Mitochondrial Myopathies Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Mitochondrial Myopathies Market Size by Country (2022-2027) & (US$ Million)
Table 62. Reata Pharmaceuticals Company Details
Table 63. Reata Pharmaceuticals Business Overview
Table 64. Reata Pharmaceuticals Mitochondrial Myopathies Product
Table 65. Reata Pharmaceuticals Revenue in Mitochondrial Myopathies Business (2016-2021) & (US$ Million)
Table 66. Reata Pharmaceuticals Recent Development
Table 67. Stealth Biotherapeutics Company Details
Table 68. Stealth Biotherapeutics Business Overview
Table 69. Stealth Biotherapeutics Mitochondrial Myopathies Product
Table 70. Stealth Biotherapeutics Revenue in Mitochondrial Myopathies Business (2016-2021) & (US$ Million)
Table 71. Stealth Biotherapeutics Recent Development
Table 72. Raptor Pharmaceutical Company Details
Table 73. Raptor Pharmaceutical Business Overview
Table 74. Raptor Pharmaceutical Mitochondrial Myopathies Product
Table 75. Raptor Pharmaceutical Revenue in Mitochondrial Myopathies Business (2016-2021) & (US$ Million)
Table 76. Raptor Pharmaceutical Recent Development
Table 77. Raym Genedx Company Details
Table 78. Raym Genedx Business Overview
Table 79. Raym Genedx Mitochondrial Myopathies Product
Table 80. Raym Genedx Revenue in Mitochondrial Myopathies Business (2016-2021) & (US$ Million)
Table 81. Raym Genedx Recent Development
Table 82. Neurovive Pharmaceutical Company Details
Table 83. Neurovive Pharmaceutical Business Overview
Table 84. Neurovive Pharmaceutical Mitochondrial Myopathies Product
Table 85. Neurovive Pharmaceutical Revenue in Mitochondrial Myopathies Business (2016-2021) & (US$ Million)
Table 86. Neurovive Pharmaceutical Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mitochondrial Myopathies Market Share by Type: 2020 VS 2027
Figure 2. Muscle Biopsy Features
Figure 3. Blood Enzyme Test Features
Figure 4. Genetic Test Features
Figure 5. Global Mitochondrial Myopathies Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Disease Research and Development Institutes Case Studies
Figure 9. Mitochondrial Myopathies Report Years Considered
Figure 10. Global Mitochondrial Myopathies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Mitochondrial Myopathies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Mitochondrial Myopathies Market Share by Regions: 2020 VS 2027
Figure 13. Global Mitochondrial Myopathies Market Share by Regions (2022-2027)
Figure 14. Global Mitochondrial Myopathies Market Share by Players in 2020
Figure 15. Global Top Mitochondrial Myopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitochondrial Myopathies as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Mitochondrial Myopathies Revenue in 2020
Figure 17. Global Mitochondrial Myopathies Revenue Market Share by Type (2016-2021)
Figure 18. Global Mitochondrial Myopathies Revenue Market Share by Type (2022-2027)
Figure 19. North America Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Mitochondrial Myopathies Market Share by Type (2016-2027)
Figure 21. North America Mitochondrial Myopathies Market Share by Application (2016-2027)
Figure 22. North America Mitochondrial Myopathies Market Share by Country (2016-2027)
Figure 23. United States Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Mitochondrial Myopathies Market Share by Type (2016-2027)
Figure 27. Europe Mitochondrial Myopathies Market Share by Application (2016-2027)
Figure 28. Europe Mitochondrial Myopathies Market Share by Country (2016-2027)
Figure 29. Germany Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Mitochondrial Myopathies Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Mitochondrial Myopathies Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Mitochondrial Myopathies Market Share by Region (2016-2027)
Figure 39. China Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Mitochondrial Myopathies Market Share by Type (2016-2027)
Figure 47. Latin America Mitochondrial Myopathies Market Share by Application (2016-2027)
Figure 48. Latin America Mitochondrial Myopathies Market Share by Country (2016-2027)
Figure 49. Mexico Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Mitochondrial Myopathies Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Mitochondrial Myopathies Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Mitochondrial Myopathies Market Share by Country (2016-2027)
Figure 55. Turkey Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Mitochondrial Myopathies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Reata Pharmaceuticals Revenue Growth Rate in Mitochondrial Myopathies Business (2016-2021)
Figure 59. Stealth Biotherapeutics Revenue Growth Rate in Mitochondrial Myopathies Business (2016-2021)
Figure 60. Raptor Pharmaceutical Revenue Growth Rate in Mitochondrial Myopathies Business (2016-2021)
Figure 61. Raym Genedx Revenue Growth Rate in Mitochondrial Myopathies Business (2016-2021)
Figure 62. Neurovive Pharmaceutical Revenue Growth Rate in Mitochondrial Myopathies Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


【掲載企業】

Reata Pharmaceuticals、Stealth Biotherapeutics、Raptor Pharmaceutical、Raym Genedx、Neurovive Pharmaceutical

★調査レポート[世界のミトコンドリアミオパチー市場規模・現状・予測2021-2027] (コード:QY21APR3823)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のミトコンドリアミオパチー市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆